Showing 1 of 1 PublicationsProspects for targeting PD-1 and PD-L1 in various tumor types.Kim JW, Eder JP. Prospects for targeting PD-1 and PD-L1 in various tumor types. Oncology 2014, 28 Suppl 3: 15-28. PMID: 25387682.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedB7-H1 AntigenCarcinoma, Small CellDrug Resistance, NeoplasmHumansKidney NeoplasmsMelanomaNeoplasmsNivolumabProgrammed Cell Death 1 ReceptorConceptsTumor typesPD-L1Death ligand 1Activated T cellsMultiple tumor typesDeath-1Immune checkpointsPD-1L1 antibodyImmune escapeClinical activityT cellsClinical developmentTumor cellsLigand 1Apoptosis switchAchilles heelHeelCellsTherapyAntibodiesReceptorsDownload Full List
Prospects for targeting PD-1 and PD-L1 in various tumor types.Kim JW, Eder JP. Prospects for targeting PD-1 and PD-L1 in various tumor types. Oncology 2014, 28 Suppl 3: 15-28. PMID: 25387682.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedB7-H1 AntigenCarcinoma, Small CellDrug Resistance, NeoplasmHumansKidney NeoplasmsMelanomaNeoplasmsNivolumabProgrammed Cell Death 1 ReceptorConceptsTumor typesPD-L1Death ligand 1Activated T cellsMultiple tumor typesDeath-1Immune checkpointsPD-1L1 antibodyImmune escapeClinical activityT cellsClinical developmentTumor cellsLigand 1Apoptosis switchAchilles heelHeelCellsTherapyAntibodiesReceptors